| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,411 |
4,008 |
$273K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,866 |
1,734 |
$95K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
647 |
622 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
3,754 |
3,466 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
972 |
946 |
$10K |
| X5622 |
|
136 |
124 |
$10K |
| 99215 |
Prolong outpt/office vis |
70 |
66 |
$5K |
| 80061 |
Lipid panel |
251 |
246 |
$3K |
| 80053 |
Comprehensive metabolic panel |
252 |
248 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
25 |
25 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
113 |
109 |
$2K |
| 90686 |
|
265 |
260 |
$2K |
| 99442 |
|
59 |
29 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
38 |
38 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
239 |
192 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24 |
24 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$950.88 |
| 92551 |
|
183 |
181 |
$945.86 |
| 85027 |
|
158 |
154 |
$884.12 |
| 96127 |
|
174 |
164 |
$710.61 |
| 84443 |
Thyroid stimulating hormone (TSH) |
40 |
39 |
$643.99 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
45 |
43 |
$383.18 |
| 90480 |
|
12 |
12 |
$322.57 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$317.04 |
| 90688 |
|
92 |
92 |
$311.89 |
| 99173 |
|
182 |
180 |
$206.44 |
| 99188 |
|
28 |
28 |
$85.90 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
28 |
27 |
$68.93 |
| 81003 |
|
29 |
26 |
$44.52 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| 90648 |
|
12 |
12 |
$0.00 |